Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 338

1.

Rapid neuroinflammatory changes in human acute intracerebral hemorrhage.

Shtaya A, Bridges LR, Esiri MM, Lam-Wong J, Nicoll JAR, Boche D, Hainsworth AH.

Ann Clin Transl Neurol. 2019 Aug;6(8):1465-1479. doi: 10.1002/acn3.50842. Epub 2019 Jul 13.

2.

Relating diffusion tensor imaging measurements to microstructural quantities in the cerebral cortex in multiple sclerosis.

McKavanagh R, Torso M, Jenkinson M, Kolasinski J, Stagg CJ, Esiri MM, McNab JA, Johansen-Berg H, Miller KL, Chance SA.

Hum Brain Mapp. 2019 Oct 15;40(15):4417-4431. doi: 10.1002/hbm.24711. Epub 2019 Jul 29.

PMID:
31355989
3.

Contribution of Fibrinogen to Inflammation and Neuronal Density in Human Traumatic Brain Injury.

Jenkins DR, Craner MJ, Esiri MM, DeLuca GC.

J Neurotrauma. 2018 Oct 1;35(19):2259-2271. doi: 10.1089/neu.2017.5291. Epub 2018 Jun 7.

PMID:
29609523
4.

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.

Wallin A, Román GC, Esiri M, Kettunen P, Svensson J, Paraskevas GP, Kapaki E.

J Alzheimers Dis. 2018;62(3):1417-1441. doi: 10.3233/JAD-170803. Review.

5.

Calretinin interneuron density in the caudate nucleus is lower in autism spectrum disorder.

Adorjan I, Ahmed B, Feher V, Torso M, Krug K, Esiri M, Chance SA, Szele FG.

Brain. 2017 Jul 1;140(7):2028-2040. doi: 10.1093/brain/awx131. Erratum in: Brain. 2019 Aug 1;142(8):e44.

6.

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.

Yates RL, Esiri MM, Palace J, Jacobs B, Perera R, DeLuca GC.

Ann Neurol. 2017 Aug;82(2):259-270. doi: 10.1002/ana.24997. Epub 2017 Aug 19.

PMID:
28719020
7.

Reply: Atherosclerosis and vascular cognitive impairment neuropathological guideline.

Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S.

Brain. 2017 Feb;140(2):e13. doi: 10.1093/brain/aww305. Epub 2016 Dec 21. No abstract available.

8.

Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Geraldes R, Esiri MM, DeLuca GC, Palace J.

Brain Pathol. 2017 Nov;27(6):707-722. doi: 10.1111/bpa.12460. Epub 2017 Mar 12. Review.

PMID:
27864848
9.

Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK.

Robinson AC, Palmer L, Love S, Hamard M, Esiri M, Ansorge O, Lett D, Attems J, Morris C, Troakes C, Selvackadunco S, King A, Al-Sarraj S, Mann DM.

Acta Neuropathol. 2016 Nov;132(5):753-755. Epub 2016 Sep 15. No abstract available.

PMID:
27638700
10.

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.

Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ.

Ann Clin Transl Neurol. 2016 Aug 28;3(10):812-818. eCollection 2016 Oct.

11.

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.

Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S.

Brain. 2016 Nov 1;139(11):2957-2969. doi: 10.1093/brain/aww214.

PMID:
27591113
12.

Age-dependent expression of VEGFR2 in deep brain arteries in small vessel disease, CADASIL, and healthy brains.

Ahmed-Jushuf F, Jiwa NS, Arwani AS, Foot P, Bridges LR, Kalaria RN, Esiri MM, Hainsworth AH.

Neurobiol Aging. 2016 Jun;42:110-5. doi: 10.1016/j.neurobiolaging.2016.03.002. Epub 2016 Mar 10.

PMID:
27143427
13.

Complement and Humoral Adaptive Immunity in the Human Choroid Plexus: Roles for Stromal Concretions, Basement Membranes, and Epithelium.

Moore GR, Laule C, Leung E, Pavlova V, Morgan BP, Esiri MM.

J Neuropathol Exp Neurol. 2016 May;75(5):415-28. doi: 10.1093/jnen/nlw017. Epub 2016 Mar 19.

14.

Obituary for Dr Sabina Strich.

Esiri M.

Neuropathol Appl Neurobiol. 2016 Feb;42(2):210-1. doi: 10.1111/nan.12287. No abstract available.

PMID:
26926459
15.

Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2015 Dec 28;4(2):49. eCollection 2015.

16.

Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.

Lee JH, Koh SQ, Guadagna S, Francis PT, Esiri MM, Chen CP, Wong PT, Dawe GS, Lai MK.

Psychopharmacology (Berl). 2016 Feb;233(4):591-8. doi: 10.1007/s00213-015-4131-7. Epub 2015 Nov 6.

PMID:
26542729
17.

Genome-wide profiling of alternative splicing in Alzheimer's disease.

Lai MK, Esiri MM, Tan MG.

Genom Data. 2014 Sep 7;2:290-2. doi: 10.1016/j.gdata.2014.09.002. eCollection 2014 Dec.

18.

The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent.

Yates SC, Zafar A, Rabai EM, Foxall JB, Nagy S, Morrison KE, Clarke C, Esiri MM, Christie S, Smith AD, Nagy Z.

PLoS One. 2015 Jan 27;10(1):e0114050. doi: 10.1371/journal.pone.0114050. eCollection 2015.

19.

Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA.

Esiri M, Chance S, Joachim C, Warden D, Smallwood A, Sloan C, Christie S, Wilcock G, Smith AD.

Brain Pathol. 2015 Jan;25(1):51-62. doi: 10.1111/bpa.12221. Review.

PMID:
25521177
20.

White matter damage in dementia. Introduction.

Love S, Esiri MM.

Brain Pathol. 2015 Jan;25(1):33-4. doi: 10.1111/bpa.12222. No abstract available.

PMID:
25521174
21.

Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people.

Bridges LR, Andoh J, Lawrence AJ, Khoong CHL, Poon W, Esiri MM, Markus HS, Hainsworth AH.

J Neuropathol Exp Neurol. 2014 Nov;73(11):1026-1033. doi: 10.1097/NEN.0000000000000124.

22.

Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease.

Mohamed NE, Lee JH, Francis PT, Esiri MM, Chen CP, Lai MK.

J Alzheimers Dis. 2015;44(2):431-7. doi: 10.3233/JAD-141764.

PMID:
25261450
23.

Olfactory Pathology in Central Nervous System Demyelinating Diseases.

DeLuca GC, Joseph A, George J, Yates RL, Hamard M, Hofer M, Esiri MM.

Brain Pathol. 2015 Sep;25(5):543-51. doi: 10.1111/bpa.12209. Epub 2014 Oct 30.

PMID:
25230202
24.

The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.

Yates RL, Esiri MM, Palace J, Mittal A, DeLuca GC.

Neuropathol Appl Neurobiol. 2015 Apr;41(3):371-84. doi: 10.1111/nan.12165.

PMID:
24964187
25.

Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2014 Mar 28;3(1):19-32. eCollection 2014. Erratum in: Am J Neurodegener Dis. 2015;4(2):49.

26.

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.

Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, Esiri MM, Love S.

Brain. 2014 May;137(Pt 5):1524-32. doi: 10.1093/brain/awu040. Epub 2014 Mar 10.

27.

Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.

Yates SC, Zafar A, Hubbard P, Nagy S, Durant S, Bicknell R, Wilcock G, Christie S, Esiri MM, Smith AD, Nagy Z.

Acta Neuropathol Commun. 2013 May 8;1:3. doi: 10.1186/2051-5960-1-3.

28.

Subventricular zone cytoarchitecture changes in autism.

Kotagiri P, Chance SA, Szele FG, Esiri MM.

Dev Neurobiol. 2014 Jan;74(1):25-41. doi: 10.1002/dneu.22127. Epub 2013 Nov 4.

29.

Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).

Esiri MM, Joachim C, Sloan C, Christie S, Agacinski G, Bridges LR, Wilcock GK, Smith AD.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):30-5. doi: 10.1097/WAD.0b013e31829b72f1.

PMID:
23842286
30.

Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.

Barker R, Wellington D, Esiri MM, Love S.

J Cereb Blood Flow Metab. 2013 Jul;33(7):1050-7. doi: 10.1038/jcbfm.2013.46. Epub 2013 Mar 27.

31.

Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.

DeLuca GC, Alterman R, Martin JL, Mittal A, Blundell S, Bird S, Beale H, Hong LS, Esiri MM.

Brain. 2013 Apr;136(Pt 4):1025-34. doi: 10.1093/brain/awt031. Epub 2013 Mar 12.

PMID:
23485854
32.

Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter.

McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Neal JW, Mann DM, Esiri M, Jellinger KA, O'Brien JT, Attems J.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):485-97. doi: 10.1111/j.1365-2990.2012.01310.x.

PMID:
23075072
33.

A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

Kolasinski J, Stagg CJ, Chance SA, Deluca GC, Esiri MM, Chang EH, Palace JA, McNab JA, Jenkinson M, Miller KL, Johansen-Berg H.

Brain. 2012 Oct;135(Pt 10):2938-51. doi: 10.1093/brain/aws242.

34.

Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains.

Exley C, House E, Polwart A, Esiri MM.

J Alzheimers Dis. 2012;31(4):725-730.

PMID:
22699848
35.

[HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis].

Liesz A, Hähnel S, Korn K, Esiri M, Hacke W, Wildemann B.

Nervenarzt. 2012 Aug;83(8):1028-34. doi: 10.1007/s00115-012-3565-y. Review. German.

PMID:
22588562
36.

Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.

Sádaba MC, Tzartos J, Paíno C, García-Villanueva M, Alvarez-Cermeño JC, Villar LM, Esiri MM.

J Neuroimmunol. 2012 Jun 15;247(1-2):86-94. doi: 10.1016/j.jneuroim.2012.03.020. Epub 2012 Apr 23.

PMID:
22531276
37.

Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.

Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bódi I, King A, Hortobágyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H, Budka H.

Neuropathol Appl Neurobiol. 2013 Feb;39(2):166-78. doi: 10.1111/j.1365-2990.2012.01272.x.

PMID:
22471883
38.

The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Richardson K, Stephan BC, Ince PG, Brayne C, Matthews FE, Esiri MM.

Curr Alzheimer Res. 2012 Jul;9(6):687-96.

PMID:
22471870
39.

Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia.

Guadagna S, Esiri MM, Williams RJ, Francis PT.

Neurobiol Aging. 2012 Dec;33(12):2798-806. doi: 10.1016/j.neurobiolaging.2012.01.015. Epub 2012 Mar 3.

PMID:
22382406
40.

Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease.

Esiri MM, Chance SA.

Alzheimers Res Ther. 2012 Mar 1;4(2):7. doi: 10.1186/alzrt105.

41.

Prefrontal cortex cytoarchitecture in normal aging and Alzheimer's disease: a relationship with IQ.

van Veluw SJ, Sawyer EK, Clover L, Cousijn H, De Jager C, Esiri MM, Chance SA.

Brain Struct Funct. 2012 Oct;217(4):797-808. doi: 10.1007/s00429-012-0381-x. Epub 2012 Feb 3.

PMID:
22302432
42.

Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?

Li G, Esiri MM, Ansorge O, DeLuca GC.

J Neuroinflammation. 2012 Jan 24;9:20. doi: 10.1186/1742-2094-9-20.

43.

Sequestration and microvascular congestion are associated with coma in human cerebral malaria.

Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, Esiri MM, Day NP, White NJ, Turner GD.

J Infect Dis. 2012 Feb 15;205(4):663-71. doi: 10.1093/infdis/jir812. Epub 2011 Dec 29. Erratum in: J Infect Dis. 2012 Nov;206(9):1483.

44.

Neuropathologic evidence of endothelial changes in cerebral small vessel disease.

Giwa MO, Williams J, Elderfield K, Jiwa NS, Bridges LR, Kalaria RN, Markus HS, Esiri MM, Hainsworth AH.

Neurology. 2012 Jan 17;78(3):167-74. doi: 10.1212/WNL.0b013e3182407968. Epub 2011 Dec 14.

PMID:
22170884
45.

Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias.

Sheng Y, Lee JH, Medhurst AD, Wilcock GK, Esiri M, Wong PT, Chen CP, Lai MK.

J Neurol Sci. 2012 Apr 15;315(1-2):110-4. doi: 10.1016/j.jns.2011.11.013. Epub 2011 Nov 29.

PMID:
22129936
46.

Aluminium, iron and copper in human brain tissues donated to the Medical Research Council's Cognitive Function and Ageing Study.

House E, Esiri M, Forster G, Ince PG, Exley C.

Metallomics. 2012 Jan;4(1):56-65. doi: 10.1039/c1mt00139f. Epub 2011 Nov 1.

PMID:
22045115
47.

TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.

Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, Yusuf I, Amin H, DuPlessis D, Troakes C, Al-Sarraj S, Sloan C, Esiri MM, Prasher VP, Allsop D, Neary D, Pickering-Brown SM, Snowden JS, Mann DM.

Acta Neuropathol. 2011 Dec;122(6):703-13. doi: 10.1007/s00401-011-0879-y. Epub 2011 Oct 4.

PMID:
21968532
48.

Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort.

Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, Esiri M.

Neuropathol Appl Neurobiol. 2012 Jun;38(4):337-43. doi: 10.1111/j.1365-2990.2011.01221.x.

PMID:
21951164
49.

Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner.

Miller KL, Stagg CJ, Douaud G, Jbabdi S, Smith SM, Behrens TEJ, Jenkinson M, Chance SA, Esiri MM, Voets NL, Jenkinson N, Aziz TZ, Turner MR, Johansen-Berg H, McNab JA.

Neuroimage. 2011 Jul 1;57(1):167-181. doi: 10.1016/j.neuroimage.2011.03.070. Epub 2011 Apr 5.

50.

Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease.

Mohamed NE, Zhao Y, Lee JH, Tan MG, Esiri MM, Wilcock GK, Smith AD, Wong PT, Chen CP, Lai MK.

Neurochem Int. 2011 Jun;58(7):820-5. doi: 10.1016/j.neuint.2011.03.010. Epub 2011 Mar 23.

PMID:
21419184

Supplemental Content

Support Center